ClinConnect ClinConnect Logo
Search / Trial NCT02103218

A Risky Sex Prevention Intervention for Middle School Age Minority Girls

Launched by UNIVERSITY OF NORTH CAROLINA, GREENSBORO · Apr 2, 2014

Trial Information

Current as of June 03, 2025

Completed

Keywords

Hiv Risky Sex Prevention Intervention

ClinConnect Summary

This is a longitudinal intervention study with a study condition intervention and a control condition intervention. Potential participants will be invited to a recruitment meeting. If they choose to participate, they will be asked to sign informed consent or assent. There are 4 data collections for moms and girls - 1 after recruitment but before the start of the intervention, 1 at the end of the intervention (after the girls 12 week intervention), 1 three months after the end of the intervention (about 6 months after recruitment), and the final data collection 9 months after the end of the ...

Gender

FEMALE

Eligibility criteria

  • Mother Inclusion Criteria:
  • Must be 21 years or older.
  • Must be daughter's primary female guardian/caregiver and she lives with me at least 50% of the time.
  • Must understand spoken and written English.
  • Must be able to provide a phone number where they can be reached and will be able to maintain contact with researchers for one year after start of study.
  • Must be able to provide or arrange reliable transportation for their daughter after each session or data collection.
  • Mother Exclusion Criteria:
  • Must not be incarcerated at the time of recruitment
  • Must not have a physical or mental health condition that may affect my or my daughter's participation in the study.
  • Daughter Inclusion Criteria:
  • Must be in middle school (grades 6-8) at the time of recruitment.
  • Must be between the ages of 11-14 at the time of recruitment.
  • Must self-identify as Black, African-American, or a mixed race that includes black or African-American.
  • Must be able to understand written and spoken English.
  • Daughter Exclusion Criteria:
  • Must not be in a classroom for developmentally delayed students in school.
  • Must not be currently pregnant at the time of recruitment.
  • Must not have a mental or physical health condition that may affect her participation in the study.
  • Must not be suspended or expelled from school at the time of recruitment.

About University Of North Carolina, Greensboro

The University of North Carolina at Greensboro (UNCG) is a distinguished institution committed to advancing knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UNCG leverages its robust academic resources and expert faculty to conduct high-quality clinical studies aimed at improving health outcomes. The university fosters a dynamic environment that encourages the exploration of diverse medical and psychological interventions, ensuring that research efforts are aligned with the needs of the community and contribute to the broader field of healthcare. Through its dedication to rigorous scientific inquiry and ethical standards, UNCG plays a pivotal role in translating research findings into practical solutions for real-world challenges.

Locations

Greensboro, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Tracy R Bartlett, PhD

Principal Investigator

University of North Carolina, Greensboro

Debra C Wallace, PhD

Study Chair

Univeristy of North Carolina, Greensboro

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials